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Summary.-A microradioimmunoassay technique is described for detecting car-
cinoembryonic antigen (CEA) in whole serum. It differs from previous methods
inbeingperformed on0-025 ml of whole serum instead of5 mlof serumextracted with
perchloric acid. The present assay was sufficiently sensitive to detect 85% of
carcinomata, localized to the colon, but positive results occurred also with certain
non-gastrointestinal cancers, chiefly lung and breast, and certain non-malignant
diseases. Many of the latter sera, with the general exception of alcoholic cirrhosis
and pancreatitis, gave negative results after extraction with perchloric acid. It is
suggested that a direct assay for CEA in whole serum may permit testing of large
numbers of sera by laboratories with facilities for radioimmunoassays.
CARCINOEMBRYONIC antigen (CEA) is
an antigen present in human foetal
digestive tissues and in cancer of these
tissues in adult life (Gold and Freedman,
1965a, 1965b; Krupey, GoldandFreedman,
1968). It may also be found in the serum
of patients with gastrointestinal cancer.
Detection of CEA in serum therefore
promises to be of aid in the diagnosis
of these cancers. A radioimmunoassay
technique for CEA has been developed
(Thomson et al., 1969; Moore et al.,
1971; LoGerfo, Krupey and Hansen,
1971) which required as an initial step
extraction of the antigen from serum
with perchloric acid. In this paper we
describe a radioimmunoassay for detec-
tion of CEA in small samples of whole
serum.
MATERIALS AND METHODS
Sera were obtained from 51 blood donors
and from 326 patients selected to include
those with various neoplastic and non-
neoplastic diseases.
Purified CEA and a goat antiserum to
CEA were generously provided by Dr P.
Gold, Montreal. Samples (20 jug) of CEA
were labelled with 1251 using chloramine T
as oxidant (Hunter and Greenwood, 1962);
the specific activity of various preparations
was 22-50 uCi/,ug. The labelled antigen
was diluted in 0 01 mol/l tris buffer, pH
7-5, containing 3%O bovine serum albumin
(BSA), to a concentration of approximately
1 ng/ml. Antiserum to CEA was diluted
in BSA-tris buffer; 25 jul of a 1 x 10-5
dilution w%ras used throughout, this giving
approximately 3000 precipitation of the
amount of 1251 CEA used. Each serum
assay was performed in duplicate in
6 x 50 mm tubes by mixing 50 ju of 1251
CEA with 25 jd of the test human serumand
25 ,ul of the diluted goat antiserum to CEA;
the tubes were held for 2 hours at 37°C
and then overnight at 4°C. We assessed 2
alternatives for precipitating complexes of
CEA with antiserum to CEA, i.e. ammonium
sulphate as used in the conventional pro-
cedure on extracted serum (Thomson et al.,
1969), and antiserum to goat gamma globulin.
Saturated ammonium sulphate (100 1ul)
was added to each tube, immediately mixed,
held for one hour at 4°C, centrifuged at
16,000 g for 10 minutes, after which 100 ,ul
samples of the supernate from each tube
were removed for counting of radioactivity.
Standard tubes included (a) 1251 CEA w"ith
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pooled normal human serum, and (b) 125I
CEA antiserum to CEA and pooled normal
human serum. A standard curve was
developed by mixing 1251 CEA with anti-
serum to CEA, normal human serum and
doubling dilutions of purified unlabelled
CEA at concentrations of 3-100 ng per ml.
Inhibition by test serum of precipitation
of 125I CEA with antiserum to CEA was
compared with the degree of inhibition
given by unlabelled purified CEA, and the
concentration of CEA in the test serum
accordingly determined; levels of lOng/ml
were detectable.
In the alternative procedure for precipita-
tion, using rabbit antiserum to goat gamma
globulin (Hoechst Australia, Limited), test
human serum was held with antiserum to
CEA at 37TC for 2 hours and overnight at
4°C before the addition of 125I CEA. After
a further period of 2 hours at 37TC and over-
night at 4°C, 100 p,l of a 1: 20 dilution of
rabbit antiserum to goat gamma globulin
was added to each tube; tubes were held
at 37TC for 2 hours and overnight at 4°C
and centrifuged, and supernates were counted
as described above, using the same sets of
controls. Aspects relating to conditions for
antigen-antibody interaction and precipita-
tion of immune complexes will be reported in
detail elsewhere. Levels of CEA in serum
of 5 ng/ml were detectable.
A third series of assays was carried
out to compare results on whole serum with
those obtained on sera extracted with per-
chloric acid. 0 1 ml of 4 mol/l perchloric
acid was added to 0 4 ml of serum whilst the
serum was agitated on a vortex mixer;
the tubes were centrifuged at 4000 g for
10 minutes and the supernate dialysed
against multiple changes of 0-01 molfl phos-
phate buffered saline, pH 7 3, for 2 days;
25 pi samples of the extract were assayed
for CEA, as described, with precipitation of
immune complexes by ammonium sulphate.
Precipitation was facilitated by adding a
5 x 10-1 dilution of normal goat serum to
the antiserum to CEA. Control tubes
contained perchloric acid extracts of pooled
normal human serum. A standard inhibition
curve was obtained by including with each
assay perchloric acid extracts of pooled
normal human serum to which had been
added, before extraction, doubling dilutions
of unlabelled CEA. When levels of CEA
were low, tests were occasionally repeated on
supernates concentrated by lyophilization.
Levels of CEA in serum of 3 ng per ml were
detectable.
RESULTS
The results of assays for CEA are
shown in Tables I and II. The inhibition
of the reaction between 125I CEA-anti
CEA produced by the test sera are
expressed as ng of CEA per ml of serum
relative to the purified CEA standard.
The results of assays for CEA in whole
serum using precipitation by rabbit anti-
goat serum (Table II) were generally
similar to those using ammonium sulphate
precipitation (Table I). However, more
sera gave detectable levels of CEA,
particularly sera from patients with
TABLE I. Detection of CEA in Whole Serum and in Extracted Serum using
Ammonium Sulphatefor Precipitation of Immune Complexes
Extracted serum*
Diagnosis
Blood donors
Miscellaneous diseasest
Cancer of colon local
disseminated
Other gastrointestinal cancer
Cancer of lung and breastt
Other cancer
Pancreatitis and alcoholic
cirrhosist
Number CEA ng/ml Number CEA ng/ml
tested < 10 10-20 > 20 tested < 3 3-15 > 15
17 16 1 - 21 20 1
35 31 1 3 . 43 39 4
12 9 2 1 17 6 9 2
9 1 1 7. 10 2 4 4
28 11 7 10 . 14 3 7 4
31 14 5 12 25 7 11 7
23 21 2. 9 5 4
12 7 1 4 . 16 4 11 1
* Serum extracted with perchloric acid.
t Excluding cancer, pancreatitis and liver disease.
I Pooled data approximately equal proportions for both (iiseases.
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TABLE II. Detection of CEA in Whole Serum u,sing Rabbit Antiserum to Goat
Gamma Globulin for Precipitation of Immune Complexes
Diagnosis
Blood donors
Miscellaneouis diseases*
Cancer of colon {oc nt clis.seminatedI
Other gastrointestinal cancer
Cancer of lung
Cancer of breast
Other cancer
Pancreatitis
Alcoholic cirrhosis
Number
tested
51
158
23
21
34
22
14
31
13
11
CEA ng/ml
<5
46
102
3
4
2
3
26
4
1
5-14 15-35 > 35
5
43
9
1
10
10
3
3
2
4
13
9
10
8
3
4
6
6
2
10
12
7
4
* Excludling canlcer, pancreatitis and alcoholic cirrhosis of the liver.
localized carcinoma of the colon. On the
other hand, more sera from patients with
diseases other than cancer gave detectable
levels of CEA. The results of assays for
CEAafterextractionofserawithperchloric
acid (Table I) show concentrations ofCEA
lower than those obtained with whole
serum; in particular, extracted sera from
6 of 17 patients with localized colonic
cancer had a concentration of CEA less
than 3 ng/ml. We draw attention to the
finding, in all procedures, of CEA in sera
of patients with non-intestinal cancers,
particularly of the lung and breast, as
well as in sera of some patients with
diseases other than cancer, particularly
cirrhosis of the liver and pancreatitis.
DISCUSSION
Early studies suggested that CEA
was specifically elevated in the sera of
patients with gastrointestinal cancer
(Thomson et al., 1969). More recent
studies, however, have shown that CEA
can also be detected in the sera ofpatients
with non-intestinal cancer, particularly
of lung and breast, in certain non-neo-
plastic diseases, particularly of gastro-
intestinal or pulmonary origin, and in
uraemia (Moore et al., 1971; LoGerfo et al.,
1971). Our present results are in accord
with these observations, in showing that
CEA was detected in association with
cancer of the colon, stomach, pancreas,
breast and lung, and in lower concentra-
tion in some non-malignant diseases.
The cases of cancer of the colon were
" staged " only to the degree ofdifferentia-
ting " local " and " disseminated " cancer;
" local " refers to cancers restricted to
the wall of the bowel (Duke's Class 1) and
" disseminated " to cancers extending
beyond the wall of the bowel (Duke's
Class 2 and 3, and distant metastases).
Other cancers were not " staged ". We
note that sera from 20 of 23 " local "
colon cancers were positive, as were all
of 21 " disseminated " cancers, using
antiglobulin precipitation of complexes
(Table II).
In previous studies (Thomson et al.,
1969; Moore et al., 1971; LoGerfo et al.,
1971), CEA was detected in serum only
after extraction with perchloric acid,
dialysis and usually lyophilization, using
approximately 5 ml of patient serum as
opposed to 0-025 ml ofwhole serum in our
modified microassay. However, it is first
relevant to compare our results on sera
extracted with perchloric acid with those
cited in previous reports. The present
microassay, using 25 1dl of extracted
serum, was sufficiently sensitive that
3 ng/ml of CEA could be detected. With
extracted sera, we found that most cases
of disseminated carcinoma of the colon,
other intestinal cancers and cancer of
the lung and breast gave values over
3 ng/ml, although sera from 6 of 17
patients with cancers known to be local-
ized to the colon had no detectable levels.CARCINOEMBRYONIC ANTIGEN IN WHOLE SERUM 359
The present studies were designed to
develop a microassay technique which
would detect CEA in small volumes of
whole serum. This was achieved in
assays in which the complexes were
precipitated by rabbit antiserum to goat
gamma globulin. This proved better
than precipitation of complexes by
ammonium sulphate; however, we note
that the lowest detectable level of CEA
was 10 ng/ml using ammonium sulphate.
Taking each ofour methodsinto considera-
tion, the highest incidence of positive
assays for CEA with normal human sera
was 10%0 (5/51), with levels between
3-1Ong/ml, all other sera having values
less than 3 ng/ml. It may be that all
human sera contain some CEA, and
considerably more work will be required
in order to derive a " normal range ".
Most of the sera from patients without
cancer which gave levels of CEA over
5 ng/ml in direct tests on whole serum
were re-assayed after extraction with
perchloric acid in order to reassess these
apparently " false positive " results. The
assay remained positive with many sera
of patients with alcoholic cirrhosis of the
liver and pancreatitis; it is assumed that
such sera do in fact contain CEA. Ofthe
4 positive sera from patients with miscell-
aneous diseases, extraction resulted in a
reduction in the level ofCEA, from greater
than 20 ng/ml to less than 15 ng/ml.
Negative results in assays for CEA using
whole serum from patients with known
cancer of the colon remained negative
after extraction. Hence, we conclude
that although a satisfactorily sensitive
microimmunoassay techniquefordetecting
CEA in whole serum was attained,
" false positive " results occur in some
conditions other than cancer, so that
positive sera should be re-assayed after
extractionwithperch]oricacid; conversely,
negative results may occur in small
cancers localized in the colon. To vali-
date further this conclusion, a larger
series of sera from patients with cancers
and other diseases is being processed by
all 3 assay methods.
The assays on whole serum reported
here were carried out by a micro-method
requiring only 25 ,ul of serum. Such
assays can therefore be performed on
fresh or stored sera drawn for other
purposes, and many determinations can
be made on the one sample. Since this
assay merely requires the addition of
reagents, centrifugation and sampling of
supernates, it should be readily adaptable
to automated techniques. Although fur-
ther studies on specificity of the assay
are required and additional modifications
may be needed to reduce the frequency of
" false positive " results in relation to
cancer, the assay for CEA in whole
serum appears applicable to the testing
of large numbers of sera by routine
laboratories with facilities for radio-
immunoassays.
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